Jefferies Upgrades Kindred Healthcare (KND) to Buy

Jefferies upgraded Kindred Healthcare (NYSE: KND) from Hold to Buy with a price target of $13 (up from $11).

The firm comments, "We are upgrading KND to Buy (from Hold) and raising our PT to $13 (from $11) after CMS issued a better-than-expected FY13 proposed LTCH rule. We believe improved reimbursement visibility will allay investor anxieties and push this highly discounted stock higher."

FY12 EPS goes from $1.50 to $1.45.

For an analyst ratings summary and ratings history on Kindred Healthcare click here. For more ratings news on Kindred Healthcare click here.

Shares of Kindred Healthcare closed at $8.30 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
• Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities